CG Oncology, Inc. - Common stock (CGON) earnings
CGON earnings moved a median of +0.47% by the close. Quarterly and annual CGON reports and results, each read against the price at its own news timestamp. Back to the CGON overview →
19 measured CGON earnings events.
Where these CGON earnings landedvs 19 measured CGON earnings reactions
| Middle 50% of CGON earnings reactions | -4.61% to +3.81% |
|---|---|
| Median reaction (to close) | +0.47% |
| Measured reactions | 19 |
Point-in-time · zero look-ahead
Half of the 19 CGON earnings events with a measured close landed between -4.61% and +3.81%; 53% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| CG Oncology Reports Second Quarter 2026 Financial Results and Provides Business Updates | Press release | +5.71% | +3.81% | |
| Form 10-Q CG Oncology, Inc. For: Jun 30 | SEC filing · Form 10-Q | +5.71% | +3.81% | |
| CG Oncology Reports First Quarter 2026 Financial Results and Provides Business Updates | Press release | +1.62% | +1.04% | |
| Form 10-Q CG Oncology, Inc. For: Mar 31 | SEC filing · Form 10-Q | +2.58% | +1.46% | |
| Form 10-K CG Oncology, Inc. For: Dec 31 | SEC filing · Form 10-K | +1.71% | +5.39% | |
| CG Oncology Reports Third Quarter 2025 Financial Results and Provides Business Updates | Press release | +0.32% | +7.86% | |
| Form 10-Q CG Oncology, Inc. For: Sep 30 | SEC filing · Form 10-Q | -1.50% | -0.43% | |
| CG Oncology Reports Second Quarter 2025 Financial Results and Provides Business Updates | Press release | -0.33% | +2.05% | |
| Form 10-Q CG Oncology, Inc. For: Jun 30 | SEC filing · Form 10-Q | -0.38% | -3.25% | |
| CG Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates | Press release | -2.65% | -5.10% | |
| Form 10-Q CG Oncology, Inc. For: Mar 31 | SEC filing · Form 10-Q | -2.65% | -5.10% | |
| Form 10-K CG Oncology, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.04% | -0.79% | |
| CG Oncology Reports Third Quarter 2024 Financial Results and Provides Business Updates | Press release | -2.19% | -6.80% | |
| Form 10-Q CG Oncology, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.19% | -4.12% | |
| CG Oncology Reports Second Quarter 2024 Financial Results and Provides Business Updates | Press release | +0.47% | +7.16% | |
| Form 10-Q CG Oncology, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.47% | +7.16% | |
| CG Oncology Reports First Quarter 2024 Financial Results and Provides Business Updates | Press release | -0.43% | -8.73% | |
| Form 10-Q CG Oncology, Inc. For: Mar 31 | SEC filing · Form 10-Q | -0.43% | -8.73% | |
| Form 10-K CG Oncology, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.47% | +0.47% |
Keep exploring
More CGON: analyst actions → · SEC filings → · CGON overview →